1. Home
  2. RCEL

RCEL

Avita Medical Inc.

Logo Avita Medical Inc.

Health Care

Medical/Dental Instruments

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Founded: N/A Country:
United States
United States
Employees: N/A City: VALENCIA
Market Cap: 241.1M IPO Year: N/A
Target Price: $28.25 AVG Volume (30 days): 221.3K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.90 EPS Growth: N/A
52 Week Low/High: $9.16 - $21.70 Next Earning Date: 05-13-2024
Revenue: $51,571,000 Revenue Growth: 37.03%
Revenue Growth (this year): 58.41% Revenue Growth (next year): 39.72%

Share on Social Networks: